|Original language||English (US)|
|Number of pages||2|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - Apr 2 2019|
Bibliographical noteFunding Information:
reported being supported by research career scientist award 10-391 from the Veterans Affairs Health Services Research and Development and support from the Durham Veterans Affairs Health Services Research and Development Center of Innovation (CIN 13-410); receiving grants from the National Institute on Drug Abuse and the Department of Veterans Affairs; receiving a contract from the National Committee for Quality Assurance to Duke University for research; and that his spouse owns stock in Amgen. No other disclosures were reported.